WOLVERINE ASSET MANAGEMENT LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 71 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2016$10,000
-92.1%
1,900
-87.5%
0.00%
-100.0%
Q4 2015$127,000
-69.3%
15,260
-61.9%
0.00%
-66.7%
Q3 2015$414,000
+21.8%
40,041
+56.1%
0.01%
+12.5%
Q2 2015$340,000
+639.1%
25,643
+748.8%
0.01%
+700.0%
Q1 2015$46,000
+17.9%
3,021
-58.6%
0.00%0.0%
Q4 2014$39,0007,299
+72890.0%
0.00%
Q2 2013$0100.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2013
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders